Michael Rossi
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Rossi
Mirion Technologies, Inc. reported in an 8-K filed October 18, 2023 that Michael Rossi resigned as Medical Group President, effective November 1, 2023. Mirion Technologies, Inc. reported in an 8-K filed October 3, 2022 that Michael Rossi was appointed Medical Group President, effective October 3, 2022.
“On October 13, 2023, Mr. Michael Rossi, who has served as the Medical Group President of Mirion Technologies, Inc. (the "Company"), notified the Company of his decision to resign from his position, effective November 1, 2023, in order to assume a CEO role at another public company.”
“On October 3, 2022, Mirion Technologies, Inc. (the "Company") announced the appointment of Michael Rossi, as Medical Group President of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Mirion Technologies, Inc. (MIR)
SEC 8-K
Current2022-10-03–present
-
Mirion Technologies, Inc. (MIR)
Proxy statement
Start not stated–2023-11-01
-
Mirion Technologies, Inc. (MIR)
Proxy statement
Start not stated–2023-11-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Mirion Technologies, Inc.
Other people whose current roles at this company are on record from its filings.
- Thomas D. Logan CEO
- Lawrence D. Kingsley Chairman, Board Member
- Lawrence Kingsley Chairman, Board Member
- Brian Schopfer CFO
- Michael Freed COO
- Christopher Moore Chief Accounting Officer
- Jody A. Markopoulos Board Member
- John W. Kuo Board Member
- Kenneth C. Bockhorst Board Member
- Robert A. Cascella Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.